Wells Fargo’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $4.93M | Sell |
|
|||||
|
2025
Q2 | $4.57M | Sell |
|
|||||
|
2025
Q1 | $5.75M | Sell |
|
|||||
|
2024
Q4 | $13.3M | Sell |
|
|||||
|
2024
Q3 | $14.3M | Sell |
|
|||||
|
2024
Q2 | $12M | Buy |
|
|||||
|
2024
Q1 | $14.6M | Buy |
|
|||||
|
2023
Q4 | $11.6M | Sell |
|
|||||
|
2023
Q3 | $14.7M | Buy |
|
|||||
|
2023
Q2 | $11M | Sell |
|
|||||
|
2023
Q1 | $14.2M | Buy |
|
|||||
|
2022
Q4 | $10.5M | Buy |
|
|||||
|
2022
Q3 | $10M | Sell |
|
|||||
|
2022
Q2 | $12.4M | Sell |
|
|||||
|
2022
Q1 | $31.9M | Buy |
|
|||||
|
2021
Q4 | $38.8M | Sell |
|
|||||
|
2021
Q3 | $267M | Buy |
|
|||||
|
2021
Q2 | $222M | Sell |
|
|||||
|
2021
Q1 | $200M | Buy |
|
|||||
|
2020
Q4 | $198M | Sell |
|
|||||
|
2020
Q3 | $213M | Sell |
|
|||||
|
2020
Q2 | $239M | Buy |
|
|||||
|
2020
Q1 | $178M | Sell |
|
|||||
|
2019
Q4 | $192M | Sell |
|
|||||
|
2019
Q3 | $223M | Buy |
|
|||||
|
2019
Q2 | $188M | Sell |
|
|||||
|
2019
Q1 | $193M | Sell |
|
|||||
|
2018
Q4 | $150M | Sell |
|
|||||
|
2018
Q3 | $215M | Sell |
|
|||||
|
2018
Q2 | $207M | Buy |
|
|||||
|
2018
Q1 | $169M | Buy |
|
|||||
|
2017
Q4 | $149M | Buy |
|
|||||
|
2017
Q3 | $119M | Buy |
|
|||||
|
2017
Q2 | $119M | Buy |
|
|||||
|
2017
Q1 | $54.1M | Sell |
|
|||||
|
2016
Q4 | $64.1M | Sell |
|
|||||
|
2016
Q3 | $89.4M | Buy |
|
|||||
|
2016
Q2 | $77.7M | Sell |
|
|||||
|
2016
Q1 | $77.8M | Sell |
|
|||||
|
2015
Q4 | $79M | Buy |
|
|||||
|
2015
Q3 | $75.1M | Sell |
|
|||||
|
2015
Q2 | $93.1M | Sell |
|
|||||
|
2015
Q1 | $87.8M | Sell |
|
|||||
|
2014
Q4 | $84.9M | Buy |
|
|||||
|
2014
Q3 | $75.9M | Sell |
|
|||||
|
2014
Q2 | $91M | Sell |
|
|||||
|
2014
Q1 | $97.6M | Buy |
|
|||||
|
2013
Q4 | $62.8M | Buy |
|
|||||
|
2013
Q3 | $49.9M | Buy |
|
|||||
|
2013
Q2 | $38.6M | Buy |
|